Literature DB >> 11247180

[Spectrum of neuropsychological changes in multiple sclerosis].

T G Alekseeva, A N Boĭko, E I Gusev.   

Abstract

Early disability of patients with multiple sclerosis at the able-bodied age is often caused by both a neurological disorder and the difficulties of their social and psychological adaptation that is aggravated significantly by higher cortical dysfunctions and by behavioral problems. The paper presents the results of the dynamic neuropsychological observation of 124 patients with multiple sclerosis and of their first degree relatives. Even at the early stage of the disease there were some cognitive disorders as worse transitent verbal, semantic, visual memory active attention and slower sensomotor reactions; difficulties in conceptual mentality. The cognitive functions, the activity of the disease, an actual psychological state, depression for example, and the expression of brain atrophy and the localization of the foci are bound by the certain way. The personality traits of patients and their close relatives testified a possible psychosomatic nature of this disease.

Entities:  

Mesh:

Year:  2000        PMID: 11247180

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


  3 in total

1.  The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

Authors:  N N Spirin; D S Kasatkin
Journal:  Neurosci Behav Physiol       Date:  2009-01

2.  Variants of personality maladaptation in patients with multiple sclerosis.

Authors:  T N Reznikova; I Yu Terent'eva; G V Kataeva
Journal:  Neurosci Behav Physiol       Date:  2007-10

3.  Characteristics of neurological and cognitive status in patients with multiple sclerosis in relation to the location and volumes of demyelination foci and the severity of brain atrophy.

Authors:  K K Mineev; L N Prakhova; A G Il'ves; G V Kataeva; A M Petrov; T N Reznikova; A V Pozdnyakov; I D Stolyarov
Journal:  Neurosci Behav Physiol       Date:  2009-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.